ARTICLE
19 November 2013

11 New Biomarkers Identified For Alzheimer’s Disease

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
A two-stage meta-analysis of genome-wide association studies (GWAS) in individuals of European ancestry identified 11 new loci associated with Alzheimer’s disease.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

A two-stage meta-analysis of genome-wide association studies (GWAS) in individuals of European ancestry identified 11 new loci associated with Alzheimer's disease. The multidisciplinary study, recently reported in Nature Genetics, ("Meta-analysis of 74,046 individuals 11 new susceptibility loci for Alzheimer's disease", published online on October 27, 2013), is a significant step toward identifying genetic risk factors for developing this devastating neurological disorder.

The study was conducted under the banner of the International Genomics of Alzheimer's Project. The analyzed data was collected from four consortia: the Alzheimer's Disease Genetic Consortium, the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium, the European Alzheimer's Disease Initiative and the Genetic and Environmental Risk in Alzheimer's Disease Consortium. The combined data sets consisted of 17,008 Alzheimer's disease cases and 37,154 controls. 11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer's disease cases and 11,312 controls. In addition to identifying the apolipoprotein E locus, 19 loci reached genome-wide significance, 11 of which are newly associated with Alzheimer's disease.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More